KoBioLabs, Inc (KOSDAQ:348150)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,360.00
-110.00 (-2.01%)
At close: Apr 28, 2026
3.08%
Market Cap 104.09B
Revenue (ttm) 69.29B
Net Income (ttm) -6.33B
Shares Out 19.42M
EPS (ttm) -326.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 60,658
Average Volume 156,157
Open 5,450.00
Previous Close 5,470.00
Day's Range 5,340.00 - 5,450.00
52-Week Range 4,180.00 - 8,730.00
Beta 0.34
RSI 51.14
Earnings Date Nov 14, 2025

About KoBioLabs

KoBioLabs, Inc. provides microbiome therapeutics for metabolic, immune, and brain diseases. The company was founded in 2014 and is based in Seoul, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 348150
Full Company Profile

Financial Performance

In 2025, KoBioLabs's revenue was 69.29 billion, an increase of 1.36% compared to the previous year's 68.36 billion. Losses were -6.33 billion, 19.5% more than in 2024.

Financial Statements

News

There is no news available yet.